Karen L. Bergman
Investor Relations Contact bij BOLT BIOTHERAPEUTICS, INC.
Profiel
Karen L.
Bergman is the founder of BCC Partners LLC.
She is currently the Vice President-Communications & Investor Relations at Bolt Biotherapeutics, Inc. Prior to this, she held the same position at ALZA Corp.
and was also the Vice President-Investor Relations & Communications at FibroGen, Inc. Ms. Bergman completed her undergraduate degree at Yale University.
Actieve functies van Karen L. Bergman
| Bedrijven | Functie | Begin |
|---|---|---|
| BOLT BIOTHERAPEUTICS, INC. | Investor Relations Contact | - |
Eerdere bekende functies van Karen L. Bergman
| Bedrijven | Functie | Einde |
|---|---|---|
| BCC Partners LLC | Founder | - |
| ALZA CORPORATION | Investor Relations Contact | - |
| FIBROGEN, INC. | Investor Relations Contact | - |
Opleiding van Karen L. Bergman
| Yale University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| FIBROGEN, INC. | Health Technology |
| BOLT BIOTHERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
| BCC Partners LLC |
